Printer Friendly

JAMES BAGIAN, M.D., JOINS SOMANETICS AS VICE PRESIDENT OF CORPORATE DEVELOPMENT AND MEDICAL AFFAIRS

 TROY, Mich., Aug. 3 /PRNewswire/ -- Gary D. Lewis, chairman, president and chief executive officer of Somanetics Corporation (NASDAQ-NMS: SMTS), announced that astronaut James P. Bagian, M.D., P.E., has joined the company as vice president of corporate development and medical affairs.
 In his position, Dr. Bagian will be responsible for coordinating the company's clinical research activities, and for identifying and exploring opportunities to broaden the company's product offerings using INVOS(R) technology. INVOS, an acronym for "in vivo optical spectroscopy," is Somanetics' proprietary technology that uses low- intensity near-infrared light to quantify various characteristics of human blood and tissue.
 Dr. Bagian comes to Somanetics from NASA, where he has been an astronaut since 1980. He has logged more than 337 hours in space on two Space Shuttle missions, including STS-40, the first dedicated life sciences Space Lab mission. Dr. Bagian also is an engineer, a flight surgeon, board certified in aerospace medicine, and has training in anesthesiology and surgery. He assisted in the planning and provision of emergency medical and rescue support for the first six Shuttle flights, and served as the astronaut office coordinator for Space Shuttle software, crew equipment and search and rescue operations.
 "Dr. Bagian's leadership ability, strong medical background and extensive experience in science, engineering and technology have already significantly furthered our organization, as a consultant and as chairman of our Scientific Advisory Board," Lewis said. "We envision even greater strides having him with us on a full-time basis."
 Dr. Bagian has served as chairman of Somanetics' Scientific Advisory Board since 1992, and has been a member since 1990. As chairman, Dr. Bagian has led a group of scientific consultants in addressing potential applications for Somanetics' INVOS technology and other technologies that provide cost-effective solutions to the critical care physician.
 The Pennsylvania native holds a medical degree from Thomas Jefferson University and a bachelor of science in mechanical engineering from Drexel University, both in Philadelphia. Dr. Bagian has received numerous honors and awards including a NASA Achievement Award in 1991 for developing the currently used treatment for space motion sickness. He also was the recipient of a NASA Exceptional Service Medal for his work on Shuttle missions STS-29 and STS-40. Somanetics Corporation, headquartered in Troy, develops, manufactures and globally markets computer-based medical diagnostic and monitoring equipment using INVOS technology. Somanetics' INVOS 3100 Cerebral Oximeter is the first product of its kind to monitor, noninvasively, directly and continuously, regional oxygen saturation of the blood in an adult's brain. The Cerebral Oximeter is intended primarily for use in a hospital's operating room, intensive care unit, recovery room and emergency room.
 Somanetics' Common Shares and Class B Warrants are publicly traded on the NASDAQ National Market under the symbol SMTS and SMTSZ, respectively.
 -0- 8/3/93
 /CONTACT: Mary Ann Robb, director of Corporate Communications, Somanetics Corporation, 313-689-3996/
 (SMTS)


CO: Somanetics Corporation ST: Michigan IN: MTC SU: PER

TM-SB -- DETU01 -- 8628 08/03/93 05:30 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 3, 1993
Words:489
Previous Article:COMPUSERVE INFORMATION MANAGER BUNDLED WITH MODEMS FROM BEST DATA, CARDINAL TECHNOLOGIES
Next Article:SYMETRICS INDUSTRIES ANNOUNCES CONTRACT AWARD
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters